10.14.24 -- Who Handles Maintenance At Your CDMO? You Should Know

This webinar will focus on how KBI Biopharma's SUREtechnology Platform™, powered by Selexis®, enables rapid advancement of new complex biologics from early development to first-in-human (FIH). Register to learn how the integration of the SUREtechnology Platform™ accelerates the creation of high-performing, stable cell lines tailored for biologics production. Learn more here.

Each month, Outsourced Pharma partners with PharmSource, part of GlobalData, to present the “Contract Manufacturing: Opportunities and Threats (CMOT) Report.” The report highlights CDMOs potentially impacted by key client events such as company acquisitions, product acquisitions and licenses, product approvals, late clinical product terminations, and FDA rejections.

Explore strategies for effective supply chain management and overcoming modern supply chain challenges in the pharmaceutical industry.

The design of bispecific antibodies requires a comprehensive assessment that takes the following aspects into account: half-life, mechanism of action, and manufacturing challenges.

Review current innovations and trends in the development of ADCs focusing on three main aspects: linker technology, drug payloads, and manufacturing.

It’s no secret – COVID-19 changed things. Now, as the pharma supply chain settles into a new normal, executives are shifting focus to better identify reliable, resilient, and forward-thinking partners.

Hear experts discuss the latest trends in antibody-drug conjugate (ADC) discovery and development and how next-generation pipelines are being shaped by payload and linker-chemistry innovations.

API supply is all about balancing risk. Preparing to ask and answer these 10 questions can provide clarity and confidence. Discover how to diversify your API supply chain.

Learn about the University of Queensland's rapid development of a vaccine candidate for COVID-19 and the role GS Xceed® system played in this project.

From identity and purity testing using chromatography and electrophoresis to PCR and microbial studies, explore advanced analytical solutions tailored for siRNA, miRNA, pDNA, and mRNA products.

See how a leading CDMO partnered with Körber to quickly deploy a high-speed packaging solution to meet tight production deadlines in the face of a global pandemic.

Partner Week is back this October! From 10/21 through 10/25, hear from CDMOs across Fill/Finish, Large Molecule, Small Molecule, Cell & Gene, and our newest addition: ADC. Bring your questions and requirements, skip the small talk, and get right down to the business of finding the best-fit partner for your short- and longer-term drug development needs. Register for free at this link.

Developability, a key factor in a biologic's success, evaluates its manufacturability, safety, and efficacy. By proactively addressing concerns, we aim to enhance the likelihood of regulatory approval.

Much more than a CMO, AbbVie is an established biopharmaceutical partner providing comprehensive support at every phase of your mAb’s development to commercial life cycle.

Equipped with advanced robotics, our automated fill line is specially designed to maximize product yield while minimizing the risks associated with operator intervention.

Uncover detailed features of a chromatography system backed by over 50 years of expertise in protein research and 30 years of experience in developing purification systems.

Centrally located in the United States, with a decades-long history in biologics development and manufacturing, Cytovance delivers ingenuity end-to-end to both large pharma and biotech clients alike.